Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

VET vs REPX: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

REPX Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 8–2 Matrix Metrics)

REPX Overall Winner 6-Pillar Tally: VET 3 – 3 REPX Matrix Metrics: VET 2 – 8 REPX

As of Nov 20, 2026, Riley Exploration Permian, Inc. (REPX) is the stronger overall head-to-head candidate over Vermilion Energy Inc. (VET) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). VET carries a Unified Composite Score of 71.1/100 (BUY) at $10.25 (17.4x Forward P/E, -0.7% operating margin), whereas REPX carries 76.5/100 (STRONG BUY) at $41.04 (3.4x Forward P/E, 45.7% operating margin).

  • Technical & Structure Timing Caution: VET is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 33.5); meanwhile REPX trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 39.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About VET vs REPX
VET NYSE
Vermilion Energy Inc.
Crude Petroleum & Natural Gas
$10.25
-1.06% 1D
Market Cap $1.6B
TTM Revenue $1.97B
Forward P/E 17.4x
Beta / 30D Vol -0.77β · 61% Vol
Unified Composite Score
71.1 / 100 BUY
Tech 84.0 Fund 71.0 Flow 56.0 Mom 70.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -3.7%), weak momentum, RSI 33
RSI-14: 33.5 · SMA20: $11.53 · SMA50: $12.01
REPX NYSE American Head-to-Head Winner
Riley Exploration Permian, Inc.
Crude Petroleum & Natural Gas
$41.04
-0.17% 1D
Market Cap $909.4M
TTM Revenue $578M
Forward P/E 3.4x
Beta / 30D Vol -0.65β · 62% Vol
Unified Composite Score
76.5 / 100 STRONG BUY
Tech 94.0 Fund 70.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 39
RSI-14: 39.3 · SMA20: $45.20 · SMA50: $44.73

6-Pillar Scorecard Institutional Category Breakdown (VET 3 – 3 REPX)

Columns: Metric · VET · REPX
1. Valuation Multiples REPX
Forward P/E 17.4x 3.4x
Trailing P/E 17.4x 8.7x
PEG Ratio 3.58x 2.84x
EV / Revenue 1.4x 1.6x
2. Growth & Scale REPX
Revenue Growth (YoY) +30.4% +88.3%
Earnings Growth (YoY) -94.9% +185.4%
TTM Revenue (USD) $1.97B $578M
Market Cap $1.6B $909.4M
3. Profitability & Quality REPX
Gross Margin 64.0% 73.7%
Operating Margin -0.7% 45.7%
Net Profit Margin -24.6% 17.3%
Return on Equity (ROE) -20.1% 16.8%
4. Balance Sheet & Cash Flow VET
Cash Generation (TTM) $1.31B $375M EBITDA
Cash Flow Margin 66.5% 64.9% EBITDA Mgn
Net Cash / Leverage $1.18B Net Debt (0.59x D/E) $28.27 Book/Sh · 16.8% ROE
Dividend Yield 5.20% 3.96%
5. Options & Positioning VET
Options Structure Phase CONSOLIDATION UNCLASSIFIED
Current IV / %ile 46.5% (23rd %ile) 74.5% (100th %ile)
Put/Call OI Skew 0.30x (Call-Skewed) N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Neutral
6. R&D & Supply-Chain Moat VET
OpEx & R&D Intensity 64.7% of Rev ($1.27B) 28.0% of Rev ($162M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning High-Margin Pricing Power Moat
Supply-Chain Role Oil & Gas E&P Operator Oil & Gas E&P Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: VET (2) vs REPX (8)
Institutional Metric VET REPX Criterion Row Edge
Market Capitalization
Scale
$1.6B $909.4M Larger Scale VET
Trailing P/E Ratio
Valuation
17.4x 8.7x Lower Multiple REPX
Forward P/E Ratio
Valuation
17.4x 3.4x Lower Multiple REPX
Revenue Growth (YoY)
Growth
+30.4% +88.3% Higher Growth REPX
Operating Margin (TTM)
Profitability
-0.7% 45.7% Higher Margin REPX
Net Profit Margin
Profitability
-24.6% 17.3% Higher Margin REPX
Return on Equity (ROE)
Capital Efficiency
-20.1% 16.8% Higher ROE REPX
52-Week Range Position
Momentum
35% ($8–$15) 56% ($24–$55) Stronger Trend REPX
Beta / 30D Volatility
Risk Regime
-0.77β · 61% Vol -0.65β · 62% Vol Lower Realized Risk VET
Unified Institutional Score
Composite Signal
71.1 / 100 (BUY) 76.5 / 100 (STRONG BUY) Higher Composite REPX
Trailing 12M Revenue (USD)
Operating Scale
$1.97B $578M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
64.0% 73.7% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
3.58x PEG · 1.4x EV/Rev 2.84x PEG · 1.6x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$1.31B ($1.18B Net Debt (0.59x D/E)) $375M EBITDA ($28.27 Book/Sh · 16.8% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon REPX +4.1 pp
VET: -23.79% · REPX: -19.69%
3M Horizon REPX +27.35 pp
VET: -18.26% · REPX: +9.09%
6M Horizon REPX +22.99 pp
VET: -16.67% · REPX: +6.32%
1Y Horizon REPX +48.4 pp
VET: +11.29% · REPX: +59.69%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on VET vs REPX. Trailing 12-month operating profitability (VET -0.7% vs REPX 45.7%) and valuation multiples (VET 17.4x vs REPX 3.4x Forward P/E) are benchmarked directly in Pillar 4 below.

VET ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.97B
Gross Margin64.0%
Op. Margin-0.7%
ROE / Fwd P/E-20.1% · 17.4x
REPX ADR TTM Benchmark FX-Normalized USD
TTM Revenue$578M
Gross Margin73.7%
Op. Margin45.7%
ROE / Fwd P/E16.8% · 3.4x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
VET CONSOLIDATION
48d in phase · OBV NEUTRAL
Current IV 46.5%
IV Percentile 23rd %ile
Put/Call OI Skew 0.30x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact VET Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
REPX UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 74.5%
IV Percentile 100th %ile
Put/Call OI Skew N/A
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact REPX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
VET Moat Profile Cyclical / Execution-Driven Positioning
Oil & Gas E&P Operator
Competes within the Oil & Gas E&P value chain with $1.6B market capitalization and -0.7% operating margin.
OpEx & R&D Reinvestment 64.7% of Rev ($1.27B)
90D Engineering Disclosures 0 Published
REPX Moat Profile High-Margin Pricing Power Moat
Oil & Gas E&P Operator
Competes within the Oil & Gas E&P value chain with $909.4M market capitalization and 45.7% operating margin.
OpEx & R&D Reinvestment 28.0% of Rev ($162M)
90D Engineering Disclosures 0 Published

Investor FAQ VET vs REPX Key Questions & Quantitative Answers

As of Nov 20, 2026, Riley Exploration Permian, Inc. (REPX) is the stronger overall head-to-head candidate over Vermilion Energy Inc. (VET) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). VET carries a Unified Composite Score of 71.1/100 (BUY) at $10.25 (17.4x Forward P/E, -0.7% operating margin), whereas REPX carries 76.5/100 (STRONG BUY) at $41.04 (3.4x Forward P/E, 45.7% operating margin). Technical & Structure Timing Caution: VET is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 33.5); meanwhile REPX trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 39.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

REPX leads the Growth & Scale pillar: VET posts +30.4% YoY revenue growth and -94.9% YoY earnings growth on $1.97B TTM revenue (64.0% gross margin, -0.7% operating margin), compared with REPX at +88.3% YoY revenue growth and +185.4% YoY earnings growth on $578M TTM revenue (73.7% gross margin, 45.7% operating margin). On trailing 12-month operating scale, VET generates $1.97B in USD-normalized revenue versus $578M for REPX. In operating R&D and SG&A reinvestment, VET deploys 64.7% of Rev ($1.27B) (0 90-day corporate R&D disclosures) versus 28.0% of Rev ($162M) (0 disclosures) for REPX.

REPX screens cheaper on headline valuation multiples. VET trades at 17.4x Forward P/E, 17.4x Trailing P/E, 3.58x PEG, and 1.4x EV/Revenue (66.5% FCF margin), whereas REPX trades at 3.4x Forward P/E, 8.7x Trailing P/E, 2.84x PEG, and 1.6x EV/Revenue (64.9% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against VET (-20.1% ROE) versus REPX (16.8% ROE) capital efficiency.

In options market volatility and institutional positioning, VET carries 46.5% implied volatility (23rd %ile, Compressed (<25th %ile)), a 0.30x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (-0.77β · 61% Vol realized risk). By comparison, REPX carries 74.5% implied volatility (100th %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.65β · 62% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.